Skip to main content
SpringerLink
Log in

Cognitive Impairments in Patients with Multiple Sclerosis: Correlations Between Neuropsychological, Neurophysiological, and Neuroimaging Parameters

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

The aim of this study was to assess the neuropsychological status of patients and their P300 cognitive evoked potentials and to attempt to evaluate the clinical significance of cerebral atrophy in multiple sclerosis (MS). Neuropsychological studies were performed in 109 patients with MS. Cognitive functions were evaluated using the mini-mental state examination (MMSE), the frontal assessment battery (FAB), the A. R. Luriya method, and P300 cognitive evoked potentials; MRI data from 71 patients were also analyzed. The results obtained from these studies led to the conclusion that changes in status and cognitive function, disease activity, and the severity of cerebral atrophy are correlated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. T. G. Alekseeva, A. N. Boiko, Yu. L. Razhba, et al., “A complex approach to assessing the cognitive and emotional-personality domains in multiple sclerosis patients,” Zh. Nevrol. Psikhiat., Rass. Skleroz, 102, 20–25 (2002).

    Google Scholar 

  2. A. N. Boiko, S. V. Petrov, E. I. Gusev, and V. A. Nesterova, “Mechanism of development of the neurodegenerative process in multiple sclerosis – the neuroprotective effect of ®-interferon formulations today and neurotrophic factors tomorrow,” Zh. Nevrol. Psikhiat., Rass. Skleroz, 103, No. 2, 83–90 (2003).

    Google Scholar 

  3. V. V. Gnezditskii, Evoked Brain Potentials in Clinical Practice [in Russian], Medpress-inform, Moscow (2003).

    Google Scholar 

  4. T. L. Demina, M. V. Davydovskaya, T. D. Zhuchenko, et al., “Studies of glatiramer acetate (Copaxone) in the treatment of patients with multiple sclerosis. Experience at the Multiple Sclerosis Center,” Zh. Nevrol. Psikhiat., Rass. Skleroz, 103, No. 2, 91–97 (2003).

    Google Scholar 

  5. O. A. Khondkarian, I. A. Zavalishin, and O. M. Nevskaya, Multiple Sclerosis, Meditsina, Moscow (1987).

    Google Scholar 

  6. M. P. Amato and V. Zipoli, “Clinical management of cognitive impairment in multiple sclerosis: a review of current evidence,” Multiple Sclerosis, 10, 73–83 (2003).

    Google Scholar 

  7. J. C. Brassington and N. V. Marsh, “Neuropsychological aspects of multiple sclerosis,” Neuropsychol. Rev., 8, 43–77 (1998).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology and Neurosurgery, Siberian State Medical University, Tomsk, Russia

    V. M. Alifirova & N. F. Musina

Authors
  1. V. M. Alifirova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. F. Musina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. M. Alifirova.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 113, No. 2, Iss. II, Multiple Sclerosis, pp. 57–60, February, 2013.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alifirova, V.M., Musina, N.F. Cognitive Impairments in Patients with Multiple Sclerosis: Correlations Between Neuropsychological, Neurophysiological, and Neuroimaging Parameters. Neurosci Behav Physi 44, 517–519 (2014). https://doi.org/10.1007/s11055-014-9942-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-014-9942-1

Keywords

Search

Navigation